TGNA
48
3
ZTS
34
-2
NUE
41
-2
UPS
60
4
COF
49
5
ALLE
23
4
AN
58
3
BXP
38
4
PRU
39
5
TGT
53
-3
JCI
45
3
MAS
52
9
PVH
39
2
SIG
26
-12
ICE
48
2
XEL
44
5
CME
55
3
APA
42
3
AMP
50
4
WBA
66
2
TGNA
48
3
ZTS
34
-2
NUE
41
-2
UPS
60
4
COF
49
5
ALLE
23
4
AN
58
3
BXP
38
4
PRU
39
5
TGT
53
-3
JCI
45
3
MAS
52
9
PVH
39
2
SIG
26
-12
ICE
48
2
XEL
44
5
CME
55
3
APA
42
3
AMP
50
4
WBA
66
2
Financhill
Back

Berkshire Hathaway Vs. BridgeBio Pharma Industry Stock Comparison

Sell
22

BRK.B
Berkshire Hathaway

Last Price:
$455.59
Seasonality Move:
5.18%
Buy
68

BBIO
BridgeBio Pharma

Last Price:
$35.73
Seasonality Move:
4.17%
Sell
22
Berkshire Hathaway (BRK.B) is a Sell

Is Berkshire Hathaway a Buy, Sell or Hold?

  • The current Berkshire Hathaway [BRK.B] share price is $450.03. The Score for BRK.B is 22, which is 56% below its historic median score of 50, and infers higher risk than normal.
  • BRK.B is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
68
BridgeBio Pharma (BBIO) is a Buy

Is BridgeBio Pharma a Buy, Sell or Hold?

  • The current BridgeBio Pharma [BBIO] share price is $35.61. The Score for BBIO is 68, which is 36% above its historic median score of 50, and infers lower risk than normal.
  • BBIO is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.

BRK.B Stock Price Chart

What is Berkshire Hathaway's stock price today?

  • The Berkshire Hathaway share price today is $450.03
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and BRK.B is experiencing buying pressure, which is a positive indicator for future bullish movement.

BBIO Stock Price Chart

What is BridgeBio Pharma's stock price today?

  • The BridgeBio Pharma share price today is $35.61
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and BBIO is experiencing buying pressure, which is a positive indicator for future bullish movement.

BRK.B Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -4.03 Sell
Relative Strength Index (14 RSI): 43.85 Sell
Chaikin Money Flow: 3698970 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (448.55 - 460.75) Sell
Bollinger Bands (100): (450.63 - 468.73) Sell

BBIO Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 1.44 Buy
Relative Strength Index (14 RSI): 79.44 Buy
Chaikin Money Flow: 4334718 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (26.55 - 30.61) Buy
Bollinger Bands (100): (24.19 - 28.69) Buy

BRK.B Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 449.68 Buy
20-day SMA: 452.47 Sell
50-day SMA: 461.12 Sell
200-day SMA: 437.81 Buy
8-day EMA: 449.38 Buy
20-day EMA: 453.32 Sell
50-day EMA: 457.24 Sell
200-day EMA: 437.36 Buy

BBIO Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 30.16 Buy
20-day SMA: 28.52 Buy
50-day SMA: 26.91 Buy
200-day SMA: 26.67 Buy
8-day EMA: 31.02 Buy
20-day EMA: 29.18 Buy
50-day EMA: 27.63 Buy
200-day EMA: 26.98 Buy

Berkshire Hathaway Earnings Growth & BRK.B Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.06 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.45 per share, and an increase next year of $0.63 per share.

BridgeBio Pharma Earnings Growth & BBIO Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.01 per share, a decrease next quarter of $0.00 per share, a decrease this year of $1.16 per share, and an increase next year of $0.70 per share.

Berkshire Hathaway Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

BridgeBio Pharma Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):